Fed batch fermentation scale up in the production of recombinant streptokinase

Abstract

Due to the high international demand of the recombinant streptokinase (Skr) produced at the National Center for Bioproducts (BioCen), it was necessary to increase the production capacity of the drug, since the current production volume does not cover the demand. A scale up of the process of fermentation of the recombinant streptokinase was made using a fed batch culture, from the bank scale towards a 300L fermenter. The scaling criteria used were: the intensive variables of the process, the relationships of volumes of the fermentation medium and inoculum, the volumetric coefficient of oxygen transfer and air volume to liquid flow relationship which were kept constant. With this scale up procedure it was possible to reproduce the results obtained at the bank scale of and to double the biomass production volume with the same equipment, fulfilling all the quality requirements of the product and to cover the current demand of the market. Techno-economic indicators demonstrated the feasibility of this option.